Don't worry about your hips or knees as you age. Arthritis in those joints isn't inevitable. Keep doing the activities you enjoy. Those hopeful words come from Rafael Sierra, M.D., an orthopedic surgeon at Mayo Clinic specializing ...
Sep 27, 2023
0
9
Virtual reality simulators can help learners improve their technical skills faster and with no risk to patients. In the field of neurosurgery, they allow medical students to practice complex operations before using a scalpel ...
Sep 19, 2023
0
46
It's an injury once seen mainly in adults, yet it's become increasingly common in younger patients. From 2000 to 2020, the number of anterior cruciate ligament (ACL) tears in children and adolescents increased between three- ...
Sep 14, 2023
0
11
A new study in Gastroenterology identifies how certain proteins in the immune system interact and lead to organ rejection. The study, which involved experiments on mice and human patients, uncovered an important communication ...
Jul 19, 2023
0
19
A combination of two established surgical techniques provides good outcomes in repair of cleft palate in infants, reports a study in the July issue of Plastic & Reconstructive Surgery.
Jun 29, 2023
0
21
Miniature microscopes attached to the heads of living mice have enabled researchers to gain important insights about the neuronal pathways behind complex behaviors. Now, researchers report a new generation of head-mounted ...
Mar 29, 2023
0
22
In the largest randomized trial conducted to compare minimally invasive and conventional cardiac surgical techniques for repairing a poorly functioning mitral valve, improvements in physical activity, as well as surgical ...
Mar 8, 2023
0
6
Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, ...
Feb 1, 2023
0
7
A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development, new research at MUSC Hollings Cancer Center shows. This new data, published recently ...
Jan 20, 2023
0
68
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein in patients with blood cancers prevented moderate and severe COVID cases. ...
Dec 16, 2022
0
18
